Background: Some epidemiological studies have identified high values of pulmonary functions as an indicator of good health. At present little is known about the distribution of these characteristics in the general adult population. Objective: The aim of this study is to describe pulmonary function in the Italian general population and to evaluate its association with some lifestyle and cardiovascular risk conditions using data of the OEC/HES (Cardiovascular Epidemiology Observatory/Health Examination Survey) Project, a cross-sectional survey based on the examination of random samples of the general population. Methods: A total of 9,108 men and women aged 35-79 years were examined between 2008 and 2012. Pulmonary function [forced expiratory volume in 1 s (FEV1) and forced vital capacity (FVC)] was measured with a spirometer and anthropometric measurements and blood pressure were also recorded, whereas lifestyle (physical activity, smoking habits), health status and drug treatment were assessed by a questionnaire. FEV1 and FVC % predicted were also calculated. Univariate analysis and a multiple linear regression were performed in order to assess associations. Results: FVC and FEV1 percent predicted values were 98.0 (95% CI 97.4-98.6) and 107.3 (95% CI 106.6-107.9) for men and 108.7 (95% CI 107.9-109.4) and 113.3 (95% CI 112.6-114.1) for women. A lower mean FEV1 and FVC % predicted value was found in smokers, individuals physically inactive during their leisure time, diabetics, obese individuals and hypertensive patients. Multivariate linear regression models confirmed the independent association between risk factors and FEV1 and FVC levels. Conclusion: Our data confirm the inverse relationship existing between pulmonary function and cardiovascular risk factors, obesity, dyslipidemias and hypertension, all of which are conditions related to chronic diseases. An early public healthcare intervention on lifestyle could be useful to reduce the decline in pulmonary function.

Keywords:
Pulmonary function, Cardiovascular risk factors, Lifestyle
1.
Arcari A, Magnacca S, Bracone F, Costanzo S, Persichillo M, Di Castelnuovo A, de Curtis A, Zito F, Schünemann HJ, et al: Relation between pulmonary function and 10-year risk for cardiovascular disease among healthy men and women in Italy: the Moli-sani Project. Eur J Prev Cardiol 2013;20:862-871.
2.
Akkermans RP, Berrevoets MA, Smeele IJ, Lucas AE, Thoonen BP, Grootens-Stekelenburg JG, Heijdra YF, van Weel C, Schermer TR: Lung function decline in relation to diagnostic criteria for airflow obstruction in respiratory symptomatic subjects. BMC Pulm Med 2012;12:12.
3.
Fry JS, Hamling JS, Lee PN: Systematic review with meta-analysis of the epidemiological evidence relating FEV1 decline to lung cancer risk. BMC Cancer 2012;12:498.
4.
Keys A, Aravanis C, Blackburn, et al: Seven Countries: A Multivariate Analysis of Death and Coronary Heart Disease. Cambridge, Harvard University Press, 1980.
5.
Walter RE, Beiser A, Givelber RJ, O'Connor GT, Gottlieb DJ: Association between glycemic state and lung function: the Framingham Heart Study. Am J Respir Crit Care Med 2003;167:911-916.
6.
Higgins MW, Enright PL, Kronmal RA, Schenker MB, Anton-Culver H, Lyles M: Smoking and lung function in elderly men and women: the cardiovascular health study. JAMA 1993;269:2741-2748.
7.
Bottai M, Pistelli F, Di Pede F, Carrozzi L, Baldacci S, Matteelli G, Scognamiglio A, Viegi G: Longitudinal changes of body mass index, spirometry and diffusion in a general population. Eur Respir J 2002:20:665-673.
8.
D'Avila Melo SM, Melo VA, Menezes Filho RS, Santos FA: Effects of progressive increase in body weight on lung function in six groups of body mass index (in Portuguese). Rev Assoc Med Bras 2011;57:509-515.
9.
Songür N, Aydin ZD, Oztürk O, Sahin U, Khayri U, Bircan A, Akkaya A: Respiratory symptoms, pulmonary function, and reproductive history: Isparta Menopause and Health Study. J Womens Health 2010;19:1145-1154.
10.
Menotti A, Conti S, Farchi G, Giampaoli S, Dima F, Seccareccia F, Giuli B, Torsello S, Morisi G, Buongiorno A: The prediction of future health in healthy middle-aged men. Eur J Epidemiol 1986;2:233-239.
11.
Lazarus R, Gore CJ, Booth M, Owen N: Effects of body composition and fat distribution on ventilatory function in adults. Am J Clin Nutr 1998;68:35-41.
12.
Giampaoli S, Vanuzzo D, Palmieri L, Lo Noce C, Dima F, De Sanctis Caiola P, Donfrancesco C, Ciccarelli P, Toccaceli V: Progetto CUORE. Epidemiologia e prevenzione delle malattie cardio-cerebrovascolari. Protocollo e manuale delle operazioni dell'Osservatorio Epidemiologico Cardiovascolare/Health Examination Survey 2008-2011. Rapporti Istisan 2010;10:80.
13.
Giampaoli S, Vanuzzo D, Research Group of the OEC/HES: La salute cardiovascolare degli italiani. Terzo Atlante Italiano delle Malattie Cardiovascolari - Edizione 2014. G Ital Cardiol 2014;15(suppl 1):7S-31S.
14.
Lazarus R, Gore CJ, Booth M, Owen N: Effects of body composition and fat distribution on ventilatory function in adults. Am J Clin Nutr 1998;68:35-41.
15.
Palmieri L, Rielli R, Demattè L, Donfrancesco C, Ciccarelli P, De Sanctis Caiola P, Dima F, Lo Noce C, Brignoli O, et al: CUORE project: implementation of the 10-year risk score. Eur J Cardiovasc Prev Rehabil 2011;18:642-649.
16.
Giampaoli S, Palmieri L, Donfrancesco C, Panico S, Vanuzzo D, Pillotto L, Ferrario M, Cesana G, Mattiello A: Cardiovascular risk assessment in Italy: the CUORE Project risk score and risk chart. Ital J Public Health 2007;5:102-109.
17.
Peslin R, Bohadana A, Hannhart B, Jardin P: Comparison of various methods for reading maximal expiratory flow-volume curves. Am Rev Respir Dis 1979;119:271-277.
18.
Maio S, Sherrill DL, MacNee W, Lange P, Costabel U, Dahle SE, Sybrecht GW, Burghuber OC, Stevenson R, et al: The European Respiratory Society spirometry tent: a unique form of screening for airway obstruction. Eur Respir J 2012;39:1458-1467.
19.
Onishi K, Yoshimoto D, Hagan GW, Jones PW: Prevalence of airflow limitation in outpatients with cardiovascular diseases in Japan. Int J Chron Obstruct Pulmon Dis 2014;9:563-568.
20.
Ostrowski S, Grzywa-Celińska A, Mieczkowska J, Rychlik M, Lachowska-Kotowska P, Lopatyński J: Pulmonary function between 40 and 80 years of age. J Physiol Pharmacol 2005:56(suppl 4):127-133.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.